Report Categories
View AllRecent Articles
View All
How Expion360 XPON responds to market challenges Volatility Increases 20260505
GDDY GoDaddy tops Q4 2025 EPS consensus estimates but shares fall 045 percent in todays trading
CUBI Cust Bancorp delivers modest Q1 2026 EPS beat shares rise 106 percent on positive investor sentiment
How ChargePoint CHPT responds when competition intensifies 047 20260506
PutinXi Talks Rekindle Power of Siberia 2 as Iran Conflict Shakes Energy Markets
Standard Chartered CEO Apologizes for Lower Value Human Capital Remark
OpenAI Eyes IPO Filing Signaling Acceleration in AI Market Race
Arsenals Enduring Cultural Influence A Financial Perspective on Brand Value Beyond Trophies
Paul Tudor Jones No Chance Kevin Warsh Can Push the Fed to Cut Rates
Fed Rate Hike Expectations for 2026 Key Market Factors Investors Should Watch
Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines
FICO Q1 2026 Earnings EPS Surges Past Estimates as Stock Gains 314
Bluelinx Holdings Q1 2026 Earnings EPS Surges Past Expectations Stock Edges Lower
CNTA Q1 2026 Earnings WiderthanExpected Loss Amid No Revenue Stock Flat
Amprius Technologies Inc AMPX Q1 2026 Earnings Loss Wider Than Expected Shares Buck the Trend
NWE Q1 2026 Earnings EPS Beats Estimates by 691 as Utility Operations Show Stability
Oxford Lane Capital Preferred OXLCO Edges Higher Approaches Key Resistance Zone
OReilly Automotive ORLY Slips Slightly Amid Mixed Market Sentiment
Canadian Pacific Kansas City CP Surges 332 on Heavy Volume Key Levels in Focus
APi Group APG Holds at 4158 Consolidation Phase as Key Levels Remain Unchanged
Eaton Vance Municipal Income 2028 Term Trust ETX Holds Steady Near 191 Amid Modest Uptick
External Links
USChina Trade Talks Resurface as Focus Shifts to APEC Summit
SIRI Q1 2026 Earnings EPS Beat Amid Subscriber Headwinds
Tredegar Corporation TG Surges 23 Approaches Key Resistance at 84
Tecogen Inc TGEN Q1 2026 Earnings Narrower Loss Surprises Street as Stock Gains 415
BRLT Q1 2026 Earnings EPS Miss Weighs on Sentiment Despite Modest Stock Gain
CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue
DHCNL Q1 2026 Earnings EPS Misses Estimates Amid Continued Operational Headwinds
JANX Q1 2026 Earnings NarrowerthanExpected Loss Buoys Biotech Sentiment
MLI Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Robust Demand
IPDN Q2 2023 Earnings Net Loss of 014 Per Share Reflects Ongoing Investment Phase